Seeking Alpha

BioMarin Pharmaceutical (BMRN +3.4%) gets a lift after announcing it's received FDA approval for...

BioMarin Pharmaceutical (BMRN +3.4%) gets a lift after announcing it's received FDA approval for the expansion of its manufacturing facility in Novato, CA. The facility will support will the company's enzyme replacement therapy portfolio, and provide up to $1B in revenue.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs